Travere Therapeutics (TVTX) Ownership - Who owns Travere Therapeutics?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

3611 Valley Centre Drive

Phone

+1 888 969-7879

Employees

380

Web

https://www.travere.com

Details

Group

Domestic Stock Funds

Fundamentals

TVTX

Capitalization

840M

P/E Ratio

N/A

Risk (Beta)

0.74

Dividend Yield

N/A

Total Cash

325M

Total Cash/Share

4.25

Total Debt

403M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

2.31%

Revenue

178M

ROE

N/A

Book Value

15.1M

P/B Ratio

55.56

Cash Flow

N/A

Earnings

-1.79

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

3.04

Current Revenue Per Employee

142410.53

Dividends Per Share - Security

N/A

EBITDA

-330.67M

Float

N/A

Float - Current

N/A

Gross Income Margin

96.19

Revenue To Assets

-22.66

Shares Held By Institutions

2.14B

Shares Outstanding - Current

76.5M

Total Liabilities

536M

Total Volume MTD

N/A

Value

-1

Gain YTD

10.456

View a ticker or compare two or three

Compare

TVTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TVTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for TVTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology